JW Holdings Corporation (KOSE:A096760) acquired remaining 32.07% stake in Jw Life Science Corporation for KRW 72.3 billion on June 14, 2013. JW Holdings will acquire 1.94 million shares of Jw Life Science Corporation. JW Life Science reported sales of KRW 89.09 billion, net income of KRW 3.17 billion, total assets of KRW 153.73 billion and shareholders' equity of KRW 68.34 billion for the year ending December 31, 2012. The transaction was resolved by the Board of JW Holdings Corporation.

JW Holdings Corporation (KOSE:A096760) completed the acquisition of remaining 32.07% stake in Jw Life Science Corporation on June 14, 2013.